SMAD2 and diabetic kidney disease: As shown in Fig 8, immunohistochemical staining showed increased phosphorylation of Smad2/3 in mice with diabetic nephropathy (DN+DMSO) when compared to the control group (Control), which was suppressed by TRAM34 (P<0.01, Fig 8).